{"acute coronary syndrome": 3.66, "anaemia": 2.63, "arteriospasm coronary": 15.56, "ascites": 4.26, "ataxia": 2.13, "blood bilirubin increased": 3.16, "blood magnesium decreased": 7.78, "blood potassium decreased": 2.46, "bone lesion": 12.36, "bone marrow failure": 2.61, "brain neoplasm": 2.91, "breast cancer metastatic": 21.61, "breast cancer recurrent": 16.57, "cardiogenic shock": 3.86, "cardiotoxicity": 29.81, "colitis": 2.54, "cytopenia": 4.13, "dehydration": 2.73, "diarrhoea": 4.39, "disease progression": 7.33, "disease recurrence": 2.21, "drug intolerance": 3.47, "drug-induced liver injury": 4.38, "dry skin": 2.46, "ejection fraction decreased": 4.54, "electrolyte imbalance": 5.45, "enteritis": 14.24, "enterocolitis": 7.55, "febrile neutropenia": 2.94, "gastrointestinal toxicity": 35.46, "granulocyte count decreased": 9.65, "granulocytopenia": 6.79, "haematotoxicity": 13.75, "hepatic failure": 2.36, "hepatic lesion": 9.84, "hepatotoxicity": 6.03, "hiccups": 2.43, "hyperammonaemic encephalopathy": 9.5, "hyperbilirubinaemia": 6.92, "hypertransaminasaemia": 4.35, "hypokalaemia": 2.34, "hypomagnesaemia": 3.53, "hypophagia": 2.13, "ileus": 3.12, "invasive ductal breast carcinoma": 6.18, "laryngospasm": 6.23, "left ventricular dysfunction": 3.82, "leukopenia": 4.79, "liver injury": 2.77, "maligt neoplasm progression": 9.04, "metastases to bone": 25.62, "metastases to central nervous system": 23.05, "metastases to liver": 23.83, "metastases to lung": 16.82, "metastases to lymph nodes": 19.42, "metastases to meninges": 11.86, "metastases to peritoneum": 12.9, "metastases to skin": 42.67, "metastasis": 6.61, "metastatic neoplasm": 9.24, "mucosal inflammation": 13.77, "myelodysplastic syndrome": 3.8, "myelosuppression": 33.5, "nail disorder": 5.02, "neoplasm progression": 4.08, "neuropathy peripheral": 8.67, "neurotoxicity": 11.86, "neutropenia": 9.17, "neutrophil count decreased": 9.07, "oesophagitis": 3.45, "osteonecrosis of jaw": 3.07, "palmar-plantar erythrodysaesthesia syndrome": 34.2, "pancytopenia": 2.83, "peripheral sensory neuropathy": 6.37, "pik3ca-activated mutation": 87.9, "platelet count decreased": 7.64, "polyneuropathy": 3.39, "portal hypertension": 8.49, "posterior reversible encephalopathy syndrome": 2.94, "product use in unapproved indication": 2.07, "pulmonary mass": 4.17, "recurrent cancer": 15.25, "red blood cell count decreased": 2.42, "skin exfoliation": 2.11, "skin fissures": 10.91, "skin toxicity": 13.58, "stomatitis": 4.98, "therapy partial responder": 6.83, "thrombocytopenia": 7.26, "tumour marker increased": 14.13, "venoocclusive liver disease": 8.76, "vomiting": 2.1, "white blood cell count decreased": 7.78}